Flexion Therapeutics, Inc. (NASDAQ:FLXN) Q3 2018 Earnings Conference Call Transcript
Nov 07, 2018 • 04:30 pm ET
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Third Quarter Financial Results Conference Call. My name is Daniel, and I will be your coordinator today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session at the end of today's call. (Operator Instructions) I'll now turn the call over to the company.
Thanks, Daniel. Good afternoon. This is Scott Young, VP for Corporate Communications and IR. Both the earnings release we issued this afternoon and an archive of this conference call can be found on the company's website at flexiontherapeutics.com. Today's call will be led by Flexion's CEO, Dr. Michael Clayman; and he is joined by Dan Deardorf, SVP of Commercial Operations; and David Arkowitz, Flexion's CFO. (Forward-Looking Cautionary Statements) I will now turn the call over to Flexion's CEO, Mike Clayman.